PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia. alsulaimankh@hotmail.com.\', \'College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. alsulaimankh@hotmail.com.\', \'Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.\', \'Pharmaceutical Care Department, King Abdulaziz Medical City (KAMC)/King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia.\', \'Department of Pharmacy Practice, Faculty of Pharmacy, King Khalid University, Abha, Saudi Arabia.\', \'Pharmaceutical Care Department, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.\', \'College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.\', \'College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.\', \'Biostatistics and Bioinformatics Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.\', \'Intensive Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13054-021-03648-9
?:hasPublicationType
?:journal
  • Critical care (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 34193235
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all